AUPH - Aurinia Pharmaceuticals Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
As of Date: 5/30/2020
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (5Y Monthly) 1.28
52-Week Change 3141.92%
S&P500 52-Week Change 310.93%
52 Week High 321.93
52 Week Low 33.52
50-Day Moving Average 316.50
200-Day Moving Average 316.14

Share Statistics

Avg Vol (3 month) 31.48M
Avg Vol (10 day) 31.47M
Shares Outstanding 5112.55M
Float 78.54M
% Held by Insiders 117.11%
% Held by Institutions 149.68%
Shares Short (May 14, 2020) 44.44M
Short Ratio (May 14, 2020) 43.6
Short % of Float (May 14, 2020) 4N/A
Short % of Shares Outstanding (May 14, 2020) 43.94%
Shares Short (prior month Apr 14, 2020) 44.74M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:50
Last Split Date 3Oct 22, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Mar 30, 2020


Profit Margin 0.00%
Operating Margin (ttm)-27,243.40%

Management Effectiveness

Return on Assets (ttm)-22.59%
Return on Equity (ttm)-63.54%

Income Statement

Revenue (ttm)318k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)0.00%
Gross Profit (ttm)-52.55M
EBITDA -85.23M
Net Income Avi to Common (ttm)-127.95M
Diluted EPS (ttm)-1.30
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)286.12M
Total Cash Per Share (mrq)2.54
Total Debt (mrq)5.85M
Total Debt/Equity (mrq)2.22
Current Ratio (mrq)21.01
Book Value Per Share (mrq)2.34

Cash Flow Statement

Operating Cash Flow (ttm)-73.02M
Levered Free Cash Flow (ttm)-40.39M